DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | NDAQ

Overview

Corporate Details

ISIN(s):: US24661P8077
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Sanara MedTech Inc. Develops med-tech for surgical, wound, and skin care, plus telehealth for providers.	United States of America	SMTI
SANUWAVE Health, Inc. Develops noninvasive shockwave & ultrasound tech for regenerative wound care.	United States of America	SNWV
Scandinavian ChemoTech AB Develops electroporation tech to enhance chemotherapy for cancer, targeting Asia & the Middle East.	Sweden	CMOTEC
Scandinavian Real Heart AB Develops a total artificial heart that mimics natural heart function for heart failure patients.	Sweden	HEART
Schott Pharma Drug containment & delivery systems (syringes, vials) for the global pharma/biotech industry.	Germany	1SXP
Scope Fluidics S.A. Biotech venture builder creating microfluidic diagnostic systems for healthcare.	Poland	SCP
Sedana Medical Develops inhaled sedation technology for mechanically ventilated patients in intensive care.	Sweden	SEDANA
SEED CO.,LTD. Japanese manufacturer of high-quality contact lenses and advanced eye care products for global markets.	Japan	7743
Semler Scientific, Inc. Provides healthcare providers with tech for early, non-invasive diagnosis of chronic diseases like PAD.	United States of America	SMLR
Senseonics Holdings, Inc. Develops the first long-term, implantable glucose sensor for diabetes management.	United States of America	SENS